Dogwood Therapeutics, Inc.
DWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818844
No open-market purchases or sales by Dogwood Therapeutics, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $6.16M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Dogwood Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 17 | 1 | 25 | +9 |
| Shares | 1.14M | 2.46K | 1.29M | +155.5K (+13.7%) |
| Value | $4.80M | $10.0K | $485.7K | −$4.31M (−89.9%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Dogwood Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Warberg Asset Management LLC | 200,000 | $74.0K | 0.02% |
| Renaissance Technologies LLC | 176,600 | $67.0K | 0.00% |
| Walleye Capital LLC | 150,000 | $57.0K | 0.00% |
| PVG Asset Management Corp | 80,590 | $30.7K | 0.12% |
| Virtu Financial LLC | 47,765 | $18.0K | 0.00% |
| UBS Group AG | 41,041 | $16.0K | 0.00% |
| Raymond James & Associates | 35,000 | $13.0K | 0.00% |
| Regions Financial Corp | 20,072 | $8.00K | 0.00% |
| Simplex Trading, LLC | 20,884 | $7.00K | 0.00% |
| Envestnet Asset Management Inc | 16,146 | $6.00K | 0.00% |
| Group One Trading, L.P. | 11,522 | $4.00K | 0.00% |
| Two Sigma Securities, LLC | 11,308 | $4.00K | 0.00% |
| Royal Bank of Canada | 33 | $0 | 0.00% |
| Cutler Group LP | 1,200 | $0 | 0.00% |
Sold out (5)
Institutions that held Dogwood Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Masters Capital Management LLC | 650,000 | $2.75M |
| Captrust Financial Advisors | 40,145 | $170.0K |
| Susquehanna International Group, LLP | 22,880 | $97.0K |
| Tower Research Capital LLC (TRC) | 1,487 | $6.00K |
| Tevis Investment Management | 75 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Dogwood Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Urban Wealth Management, LLC | 2,455 | $10.0K |